MetaADEDB 2.0 @ LMMD
salmon calcitonin
(BBBFJLBPOGFECG-UHFFFAOYSA-N)
Structure
SMILES
NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1CCCC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(C(=O)N1CCCC1C(=O)N)C(O)C)CO)C(O)C)CC(=O)N)C(O)C)CCCNC(=N)N)Cc1ccc(cc1)O)C(O)C)CCC(=O)N)CC(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(C(C)C)NC(=O)C1CSSCC(N)C(=O)NC(CO)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)C(O)C)CO)CC(C)C)CC(=O)N)CC(C)C)CCCCN)CC(C)C)CO)CCC(=O)N)CCC(=O)O)CC(C)C)Cc1[nH]cnc1
Molecular Formula:
C145H240N44O48S2
Molecular Weight:
3431.850
Log P:
-3.8963
Hydrogen Bond Acceptor:
93
Hydrogen Bond Donor:
52
TPSA:
1558.81
CAS Number(s):
N/A
Synonym(s)
1.
salmon calcitonin
2.
Calcihexal
3.
Calcimar
4.
Forcaltonin
5.
Fortical
6.
Miacalcic
7.
Miacalcin
8.
calcitonin salmon
9.
recombinant salmon calcitonin
10.
salcatonin
11.
salmon calcitonin (1-32)
12.
synthetic salmon calcitonin
External Link(s)
MeSHC028815
PubChem Compound16163442
16129616
56947124
KEGGcpd:C06865
dr:D00249
Therapeutic Target DatabaseD0I1XG
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 36
Canada Vigilance: 6
Canada Vigilance
US FAERS
2VomitingFAERS: 29US FAERS
3DizzinessFAERS: 27
Canada Vigilance: 2
Canada Vigilance
US FAERS
4Drug ineffectiveFAERS: 25
Canada Vigilance: 20
Canada Vigilance
US FAERS
5ArthralgiaFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
6Back PainFAERS: 22
Canada Vigilance: 2
Canada Vigilance
US FAERS
7EpistaxisFAERS: 21US FAERS
8PainFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
9HeadacheFAERS: 16
Canada Vigilance: 2
Canada Vigilance
US FAERS
10Nasal discomfortFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
11FlushingFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
12PalpitationsFAERS: 15
Canada Vigilance: 2
Canada Vigilance
US FAERS
13SyncopeFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
14ChillsFAERS: 11US FAERS
15FatigueFAERS: 11
Canada Vigilance: 3
Canada Vigilance
US FAERS
16Abdominal PainFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
17Chest discomfortFAERS: 10US FAERS
18AstheniaFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
19OsteoporosisFAERS: 9
Canada Vigilance: 7
Canada Vigilance
US FAERS
20Bone painFAERS: 8
Canada Vigilance: 7
Canada Vigilance
US FAERS
21ErythemaFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
22Feeling abnormalFAERS: 8US FAERS
23MyalgiaFAERS: 8US FAERS
24SneezingFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
25Bone density decreasedFAERS: 7US FAERS
26FractureFAERS: 7US FAERS
27HypersensitivityFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
28MalaiseFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
29Pharmaceutical product complaintFAERS: 7US FAERS
30TachycardiaFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
31Burning sensationFAERS: 6US FAERS
32Electrocardiogram abnormalFAERS: 6US FAERS
33Myocardial InfarctionFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
34ThrombosisFAERS: 6US FAERS
35TremorFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
36Anaphylactic shockFAERS: 5US FAERS
37BronchitisFAERS: 5US FAERS
38Chest PainFAERS: 5
Canada Vigilance: 4
Canada Vigilance
US FAERS
39Eye painFAERS: 5US FAERS
40ShockFAERS: 5US FAERS
41VertigoFAERS: 5US FAERS
42AnosmiaFAERS: 4US FAERS
43Cardiac ArrestFAERS: 4US FAERS
44Cold sweatFAERS: 4US FAERS
45Disease ProgressionFAERS: 4US FAERS
46Incorrect route of drug administrationFAERS: 4US FAERS
47PallorFAERS: 4US FAERS
48PruritusFAERS: 4US FAERS
49Rash erythematousFAERS: 4US FAERS
50Spinal column injuryFAERS: 4US FAERS
51UrticariaFAERS: 4US FAERS
52Angle Closure GlaucomaFAERS: 3US FAERS
53Ankle FractureFAERS: 3US FAERS
54AnxietyFAERS: 3US FAERS
55Blood sodium decreasedFAERS: 3US FAERS
56Compression fractureFAERS: 3US FAERS
57DeafnessFAERS: 3US FAERS
58Device FailureFAERS: 3US FAERS
59Drug exposure during pregnancyFAERS: 3US FAERS
60GlaucomaFAERS: 3US FAERS
61Hepatitis CFAERS: 3US FAERS
62HypotensionFAERS: 3US FAERS
63Intestinal resectionFAERS: 3US FAERS
64Joint injuryFAERS: 3US FAERS
65Joint swellingFAERS: 3US FAERS
66Medication ErrorFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
67Mucosal InfectionFAERS: 3US FAERS
68Oropharyngeal painFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
69OsteopeniaFAERS: 3US FAERS
70PneumoniaFAERS: 3US FAERS
71PneumonitisFAERS: 3US FAERS
72PolyuriaFAERS: 3US FAERS
73Retinal DetachmentFAERS: 3US FAERS
74RhinitisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
75Sinus headacheFAERS: 3US FAERS
76StomatitisFAERS: 3US FAERS
77Throat irritationFAERS: 3US FAERS
78Visual ImpairmentFAERS: 3US FAERS
79Weight decreasedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
80AgeusiaFAERS: 2US FAERS
81Alanine Aminotransferase IncreasedFAERS: 2US FAERS
82AlopeciaFAERS: 2US FAERS
83AngioplastyFAERS: 2US FAERS
84AphagiaFAERS: 2US FAERS
85ArthritisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
86Aspartate Aminotransferase IncreasedFAERS: 2US FAERS
87AsthmaFAERS: 2US FAERS
88Atrial FibrillationFAERS: 2US FAERS
89Atrial FlutterFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
90Blood alkaline phosphatase increasedFAERS: 2US FAERS
91Blood amylase decreasedFAERS: 2US FAERS
92Blood creatine phosphokinase MBFAERS: 2US FAERS
93Blood creatine phosphokinase increasedFAERS: 2US FAERS
94CalcinosisFAERS: 2US FAERS
95Cerebral artery occlusionFAERS: 2US FAERS
96CheilitisFAERS: 2US FAERS
97Choking sensationFAERS: 2US FAERS
98DyspepsiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
99DysphoniaFAERS: 2US FAERS
100EnchondromaFAERS: 2US FAERS
101Erythema MultiformeFAERS: 2US FAERS
102Gastrointestinal PainFAERS: 2US FAERS
103Hepatitis C RNA positiveFAERS: 2US FAERS
104InfectionFAERS: 2US FAERS
105Injection site painFAERS: 2US FAERS
106Intervertebral Disc DegenerationFAERS: 2US FAERS
107Intervertebral disc compressionFAERS: 2US FAERS
108Lip exfoliationFAERS: 2US FAERS
109Lip swellingFAERS: 2US FAERS
110MalabsorptionFAERS: 2US FAERS
111MetaplasiaFAERS: 2US FAERS
112NephrolithiasisFAERS: 2US FAERS
113Rheumatoid ArthritisFAERS: 2US FAERS
114Shoulder DystociaFAERS: 2US FAERS
115SinusitisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
116SpondylitisFAERS: 2US FAERS
117ThirstFAERS: 2US FAERS
118Ultrasound scan abnormalFAERS: 2US FAERS
119Urinary tract infectionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
120Vascular calcificationFAERS: 2US FAERS
121Visual disturbanceFAERS: 2US FAERS
122AbasiaFAERS: 1US FAERS
123Abdominal discomfortFAERS: 1US FAERS
124Accidental overdoseFAERS: 1US FAERS
125Activities of daily living impairedFAERS: 1US FAERS
126Adverse eventFAERS: 1US FAERS
127AgitationFAERS: 1US FAERS
128Altered state of consciousnessFAERS: 1US FAERS
129AmnesiaFAERS: 1US FAERS
130Application site irritationFAERS: 1US FAERS
131Basal cell carcinomaFAERS: 1US FAERS
132BiopsyFAERS: 1US FAERS
133BlepharitisFAERS: 1US FAERS
134BlindnessFAERS: 1US FAERS
135Blood creatinine increasedFAERS: 1US FAERS
136Blood glucose increasedFAERS: 1US FAERS
137Blood parathyroid hormone decreasedFAERS: 1US FAERS
138Bone graft removalFAERS: 1US FAERS
139Breast cancer recurrentFAERS: 1US FAERS
140BronchospasmFAERS: 1US FAERS
141Carotid artery occlusionFAERS: 1US FAERS
142Cataract operationFAERS: 1US FAERS
143CataractFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
144Cerebrovascular accidentFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
145Colonoscopy abnormalFAERS: 1US FAERS
146Complex partial seizuresFAERS: 1US FAERS
147CystitisFAERS: 1US FAERS
148CystFAERS: 1US FAERS
149Deafness NeurosensoryFAERS: 1US FAERS
150DehydrationFAERS: 1US FAERS
151Depressed Level of ConsciousnessFAERS: 1US FAERS
152Device related infectionFAERS: 1US FAERS
153Diabetes MellitusFAERS: 1US FAERS
154DiscomfortFAERS: 1US FAERS
155DiverticulitisFAERS: 1US FAERS
156Drug administration errorFAERS: 1US FAERS
157Drug label confusionFAERS: 1US FAERS
158DysgeusiaFAERS: 1US FAERS
159Ear discomfortFAERS: 1US FAERS
160Embolic strokeFAERS: 1US FAERS
161EructationFAERS: 1US FAERS
162Euphoric moodFAERS: 1US FAERS
163Eye InfectionFAERS: 1US FAERS
164Facial PainFAERS: 1US FAERS
165Facial asymmetryFAERS: 1US FAERS
166Feeling ColdFAERS: 1US FAERS
167FlatulenceFAERS: 1US FAERS
168Gastrointestinal carcinomaFAERS: 1US FAERS
169HemiplegiaFAERS: 1US FAERS
170HypercalciuriaFAERS: 1US FAERS
171Increased upper airway secretionFAERS: 1US FAERS
172InfluenzaFAERS: 1US FAERS
173Injection site calcificationFAERS: 1US FAERS
174Injection site inflammationFAERS: 1US FAERS
175Lichen PlanusFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
176Limb discomfortFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
177Limb injuryFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
178LymphomaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
179Malignant melanoma in situFAERS: 1US FAERS
180MastitisFAERS: 1US FAERS
181Medical device complicationFAERS: 1US FAERS
182Memory impairmentFAERS: 1US FAERS
183Mental impairmentFAERS: 1US FAERS
184Migraine with AuraFAERS: 1US FAERS
185MonoparesisFAERS: 1US FAERS
186Muscle tightnessFAERS: 1US FAERS
187Musculoskeletal discomfortFAERS: 1US FAERS
188MyositisFAERS: 1US FAERS
189Nasal mucosal disorderFAERS: 1US FAERS
190Nasal pruritusFAERS: 1US FAERS
191NervousnessFAERS: 1US FAERS
192No adverse eventFAERS: 1US FAERS
193NocturiaFAERS: 1US FAERS
194Occult blood positiveFAERS: 1US FAERS
195OnychoclasisFAERS: 1US FAERS
196Oropharyngeal swellingFAERS: 1US FAERS
197OsteolysisFAERS: 1US FAERS
198OsteosarcomaFAERS: 1US FAERS
199ParathyroidectomyFAERS: 1US FAERS
200Pathological fractureFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
201Peripheral swellingFAERS: 1US FAERS
202Pharyngolaryngeal PainFAERS: 1US FAERS
203PhlebitisFAERS: 1US FAERS
204Physical disabilityFAERS: 1US FAERS
205Plantar erythemaFAERS: 1US FAERS
206Polymyalgia RheumaticaFAERS: 1US FAERS
207Poor quality drug administeredFAERS: 1US FAERS
208Pre-EclampsiaFAERS: 1US FAERS
209Product container seal issueFAERS: 1US FAERS
210Product formulation issueFAERS: 1US FAERS
211Product label issueFAERS: 1US FAERS
212Product substitution issueFAERS: 1US FAERS
213Product use issueFAERS: 1US FAERS
214ProteinuriaFAERS: 1US FAERS
215Rectal tenesmusFAERS: 1US FAERS
216Renal painFAERS: 1US FAERS
217Respiratory tract congestionFAERS: 1US FAERS
218Retinal vascular occlusionFAERS: 1US FAERS
219RhinalgiaFAERS: 1US FAERS
220ScabFAERS: 1US FAERS
221Secretion dischargeFAERS: 1US FAERS
222SepsisFAERS: 1US FAERS
223Sinus TachycardiaFAERS: 1US FAERS
224Sinus painFAERS: 1US FAERS
225Sjogren's SyndromeFAERS: 1US FAERS
226Skin UlcerFAERS: 1US FAERS
227Skin neoplasm excisionFAERS: 1US FAERS
228Skin reactionFAERS: 1US FAERS
229SplenectomyFAERS: 1US FAERS
230SplenomegalyFAERS: 1US FAERS
231Squamous cell carcinomaFAERS: 1US FAERS
232SwellingFAERS: 1US FAERS
233TachyphylaxisFAERS: 1US FAERS
234Temperature intoleranceFAERS: 1US FAERS
235Therapeutic procedureFAERS: 1US FAERS
236Thermal burnFAERS: 1US FAERS
237Thyroid NeoplasmFAERS: 1US FAERS
238Tooth ErosionFAERS: 1US FAERS
239Tooth ResorptionFAERS: 1US FAERS
240Toxicity to various agentsFAERS: 1US FAERS
241Urinary IncontinenceFAERS: 1US FAERS
242Urinary RetentionFAERS: 1US FAERS
243Urine amylase increasedFAERS: 1US FAERS
244Urine output increasedFAERS: 1US FAERS
245VertebroplastyFAERS: 1US FAERS
246Viral pericarditisFAERS: 1US FAERS
247WheezingFAERS: 1US FAERS
248treatment failureFAERS: 1US FAERS
249Corneal OpacityCanada Vigilance: 1Canada Vigilance
250DiplopiaCanada Vigilance: 1Canada Vigilance
251Facial paralysisCanada Vigilance: 1Canada Vigilance
252HypomaniaCanada Vigilance: 1Canada Vigilance
253Injection Site ReactionCanada Vigilance: 1Canada Vigilance
254Musculoskeletal PainCanada Vigilance: 1Canada Vigilance
255Neck PainCanada Vigilance: 1Canada Vigilance
256Osteitis Deformans1933580CTD
257Pharyngeal swellingCanada Vigilance: 1Canada Vigilance
258Quality of life decreasedCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.